After many rectifications, the illegal treatment of stem cells and immune cells is still undercover.
Liao Xiong Deng is an opponent of this status quo. After the "Wei Zexi incident" was exposed in 2016, Liao Xiong Deng remembered that his father who had cancer had received immune cell therapy three years ago. "It took nearly 100,000 yuan in 7 days and died a few months later." Since then, he began to look for the Beijing bio company that contacted the year - immune cells and stem cells are the company's business.
Both immune cells and stem cell therapy are regarded as important directions in global medicine, and research results are becoming more and more abundant. However, even in developed countries, the effectiveness or safety of most stem cell and immune cell therapy is still at the stage of demonstration. The attitude of the National Health and Family Planning Commission is that, in addition to hematopoietic stem cell transplantation for the treatment of hematological diseases, the above-mentioned cell therapy is in the clinical research stage, and it is temporarily unavailable for clinical treatment, and it is not possible to charge for treatment.
A company brochure called "China's first stem cell brand", in addition to stem cell therapy, also introduced DC-CIK immunotherapy, claiming that the therapy is suitable for lung cancer, liver cancer, stomach cancer and so on. Wei Zexi used this therapy before. Intern Zhang Ma Rui / photo
However, these cell technologies or preparations that are still in the research stage in China have been used by some institutions for profit and “renovationâ€. The patient is a "white mouse" while saving money. The interviewed scholars are worried that if the illegal operation continues to prevail, the true compliant cell treatment in the future may be overdrawn and credible.
The organization that renders the effect of cell therapy dazzles patients
In 2013, after introduction, Liao Xiongden contacted Beijing Xiangcheng Jun Bioengineering Technology Co., Ltd. for his 68-year-old father and began to contact immune cell therapy.
Liao's father suffered from advanced lung cancer. On June 28, he was admitted to the neurovascular surgery ward of a hospital in Beijing. On the same day, Liao Xiong Deng transferred the first account to the personal account of the legal representative of Xiang Chengjun.
The hospital's hospitalization data showed that Liao's father was diagnosed with lung cancer brain metastasis and received four “cell transplantations†on the fourth day after admission. "Treatment is to import NK cells into the body through a blood transfusion device, just like an infusion, and lose it every two days. When the father loses, he is discharged." Liao Xiong Deng said.
NK cells are an important immune cell in the human body and have strong anti-tumor functions. Some studies suggest that if the cultured NK cells or other immune cells are reinjected into the human body, it can enhance immunity and treat cancer. This treatment is also regarded as the fourth cancer treatment tactic in addition to surgery, chemotherapy and radiotherapy. .
Liao Xiong Deng once mistakenly thought that NK cells are a kind of stem cells. Stem cells are another business of Xiangcheng Jun. This kind of cells, like "seeds", can differentiate into cells with different functions and even new tissues and organs under certain conditions. Researchers hope that this feature can be cured by replacing or replacing the patient's condition.
Hu Qingqi, former deputy director general of the World Health Organization, told reporters that stem cell research in China started earlier. Some institutions directly used the stem cells under study for clinical treatment. “There were many hospitals that advertised stem cell therapy.â€
Workwear is clothing worn for work, especially work that involves manuallabour.
Often those employed within trade industries elect to be outfitted in
workwear because it is built to provide durability and safety.
The
workwear clothing industry is growing and consumers have numerous
retailers to choose from. Chains that have made a commitment to the $1
billion and rising workwear business report steady 6 percent to 8
percent annual gains in men's workwear.
In
the UK, if workwear is provided to an employee without a logo, it may
be subject to income tax being levied on the employee for a "payment in
kind." However, if company clothing is provided with logos on then the
employee may be entitled to a tax rebate to help pay for the upkeep.
Work Wear,Men Work Wear,Women Work Wear,Breathable Work Clothes
Greateagle Safety Products Co., Ltd. , https://www.greateaglesafety.com